Publications - Page 12 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Hypertension pulmonaire (HTP) 31/08/23
Severe pre-capillary pulmonary hypertension associated with kyphoscoliosis: Description of 4 cases.

Martin G, Canuet M, Rahli M, Schuller A, Enache I, Kessler R, Riou M.

Respir Med Res. 2023 Aug 23;84:101034.
Hypertension pulmonaire (HTP) 31/08/23
Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study.

Degering J, Egenlauf B, Harutyunova S, Benjamin N, Salkić A, Xanthouli P, Eichstaedt CA, Seeger R, Sitbon O, Grünig E.

Respir Res. 2023 Jan 18;24(1):18.
Hypertension pulmonaire (HTP) 31/08/23
Knowledge exchange between patient and pharmacist: A mixed methods study to explore the role of pharmacists in patient education and counseling in asthma and pulmonary arterial hypertension.

Renet S, Chaumais MC, Gallant-Dewavrin M, Jouet E, Bezie Y, Humbert M, Rieutord A, Las Vergnas O.

Ann Pharm Fr. 2023 Jan;81(1):53-63.
Hypertension pulmonaire (HTP) 31/08/23
Diagnostic Performance of Pulsed Doppler Ultrasound of the Common Femoral Vein to Detect Elevated Right Atrial Pressure in Pulmonary Hypertension.

Croquette M, Puyade M, Montani D, Jutant EM, De Géa M, Lanéelle D, Thollot C, Trihan JE.

J Cardiovasc Transl Res. 2023 Feb;16(1):141-151.
Hypertension pulmonaire (HTP) 31/08/23
Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity.

Chomette L, Hupkens E, Romitti M, Dewachter L, Vachiéry JL, Bailly S, Costagliola S, Smits G, Tillet E, Bondue A.

Am J Med Genet A. 2023 Aug;191(8):2064-2073.
Hypertension pulmonaire (HTP) 31/08/23
Lung Dual-Energy CT Perfusion Blood Volume as a Marker of Severity in Chronic Thromboembolic Pulmonary Hypertension.

Si-Mohamed SA, Zumbihl L, Turquier S, Boccalini S, Mornex JF, Douek P, Cottin V, Boussel L.

Diagnostics (Basel). 2023 Feb 17;13(4):769.
Hypertension pulmonaire (HTP) 31/08/23
The Influence of Methods for Cardiac Output Determination on the Diagnosis of Precapillary Pulmonary Hypertension: A Mathematical Model.

Genecand L, Simian G, Desponds R, Wacker J, Ulrich S, Lechartier B, Fellrath JM, Sitbon O, Beghetti M, Lador F.

J Clin Med. 2023 Jan 4;12(2):410.
Hypertension pulmonaire (HTP) 31/08/23
Long-term Outcome of Children with Newly Diagnosed Pulmonary Arterial Hypertension: Results From the Global TOPP-registry.

Ploegstra MJ, Dunbar Ivy D, Beghetti M, Bonnet D, Alehan D, Ablonczy L, Mattos S, Bowers D, Humpl T, Berger RMF; TOPP Investigators.

Eur Heart J Qual Care Clin Outcomes. 2023 Mar 27:qcad020.
Hypertension pulmonaire (HTP) 31/08/23
Changes in the management of chronic thromboembolic pulmonary hypertension over a 10-year period, in a French expert regional competence centre.

Provost M, Mornex JF, Nasser M, Zeghmar S, Traclet J, Ahmad K, Lestelle F, Chour A, Diesler R, Cottin V, Turquier S.

Respir Med Res. 2023 Jun 3;84:101021.
Hypertension pulmonaire (HTP) 31/08/23
Do Low-Risk Pulmonary Arterial Hypertension Patients Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.

Fauvel C, Liu Y, Correa-Jaque P, Kanwar MK, Vizza CD, Lin S, Benza RL.

Chest. 2023 Jun 24:S0012-3692(23)00925-X.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Severe pre-capillary pulmonary hypertension associated with kyphoscoliosis: Description of 4 cases.

Tolerability, safety and survival in patients with severe pulmonary arterial hypertension treated with intravenous epoprostenol (Veletri®): a prospective, 6-months, open label, observational, non-interventional study.

Knowledge exchange between patient and pharmacist: A mixed methods study to explore the role of pharmacists in patient education and counseling in asthma and pulmonary arterial hypertension.

Diagnostic Performance of Pulsed Doppler Ultrasound of the Common Femoral Vein to Detect Elevated Right Atrial Pressure in Pulmonary Hypertension.

Pediatric pulmonary arterial hypertension due to a novel homozygous GDF2 missense variant affecting BMP9 processing and activity.

Lung Dual-Energy CT Perfusion Blood Volume as a Marker of Severity in Chronic Thromboembolic Pulmonary Hypertension.

The Influence of Methods for Cardiac Output Determination on the Diagnosis of Precapillary Pulmonary Hypertension: A Mathematical Model.

Long-term Outcome of Children with Newly Diagnosed Pulmonary Arterial Hypertension: Results From the Global TOPP-registry.

Changes in the management of chronic thromboembolic pulmonary hypertension over a 10-year period, in a French expert regional competence centre.

Do Low-Risk Pulmonary Arterial Hypertension Patients Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.